Acupoint Injection Of Compound Anisodine Diemailing Intravenous Treatment Of Ischemic Optic Neuropathy Clinical And Experimental,

Anterior ischemic optic neuropathy (AION). Nutritional optic nerve are small vessel obstruction happened, ischemic, caused by partial loss of optic nerve head blood supply in order to sudden visual distrurbance, quadrant pattern visual field defect associated with optic nerver head edema and striate hemorrhage. Modern medicine research, the optic nerve nutrition blood vessel due to acute circulatory disturbance caused ischemic lesion of the optic disc. AION The age of onset from 11-90 years old. Most studies show the average age at onset of disease at 57 ~ 65 years old, 55 ~ 70 years are the peak period of incidence.Clinical up to integrated traditional Chinese and Western medicine.Compound anisodine injection clinical application in ophthalmology, quite a number of reports. Die-mailing injection in ophthalmology for the treatment of a variety of reasons arising from the retina, optic nerve diseases such as. However, this combined effects of two drugs has not yet been studied systematically. AION treatment in order to further explore an effective method, this research through clinical observation and experimental study to examine the compound anisodine injection United Die-mailing injection in treatment of cancer.The results of this study show that acupoint injection of compound anisodine injection United Die-mailing injection AION after treatment, the patient's visual acuity and field of vision compared with the control group there has been a marked improvement on the effect of combination therapy was superior to a simple application of compound Lauraceae Liu alkali injection. Worthy of further clinical research and extension.